New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos
Breakthroughs March 28,2024
Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos
Breakthroughs March 28,2024
Researchers pinpoint issue that could be hampering common chemotherapy drug

Researchers pinpoint issue that could be hampering common chemotherapy drug

by Anika Hazra,University of TorontoGenome-wide CRISPR–Cas9 screens reveal modulators of gemcitabine sensitivity. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00742-zResearche
Breakthroughs March 28,2024
Researchers pinpoint issue that could be hampering common chemotherapy drug

Researchers pinpoint issue that could be hampering common chemotherapy drug

by Anika Hazra,University of TorontoGenome-wide CRISPR–Cas9 screens reveal modulators of gemcitabine sensitivity. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00742-zResearche
Breakthroughs March 28,2024
Choosing over the counter drugs for COVID 19? It's complicated

Choosing over the counter drugs for COVID 19? It's complicated

byFlorida Atlantic UniversityResearchers take a closer look at both the potential benefits and risks of acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs)—such as ibuprofen, as well a
Breakthroughs March 28,2024
Choosing over the counter drugs for COVID 19? It's complicated

Choosing over the counter drugs for COVID 19? It's complicated

byFlorida Atlantic UniversityResearchers take a closer look at both the potential benefits and risks of acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs)—such as ibuprofen, as well a
Breakthroughs March 28,2024
Mimicking exercise with a pill

Mimicking exercise with a pill

byAmerican Chemical SocietyCredit: Unsplash/CC0 Public DomainDoctors have long prescribed exercise to improve and protect health. In the future, a pill may offer some of the same benefits as exe
Breakthroughs March 28,2024
Mimicking exercise with a pill

Mimicking exercise with a pill

byAmerican Chemical SocietyCredit: Unsplash/CC0 Public DomainDoctors have long prescribed exercise to improve and protect health. In the future, a pill may offer some of the same benefits as exe
Breakthroughs March 28,2024
Can over-the-counter cold medicine treat COVID-19?

Can over-the-counter cold medicine treat COVID-19?

byCardiff UniversityCredit: Tima Miroshnichenko from PexelsResearch by Cardiff University shows that over-the-counter cold and flu treatments are safe and effective for managing mild COVID-19 sy
Breakthroughs March 28,2024
Can over-the-counter cold medicine treat COVID-19?

Can over-the-counter cold medicine treat COVID-19?

byCardiff UniversityCredit: Tima Miroshnichenko from PexelsResearch by Cardiff University shows that over-the-counter cold and flu treatments are safe and effective for managing mild COVID-19 sy
Breakthroughs March 28,2024
Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

by Sichuan International Medical Exchange and Promotion AssociationTargets primarily include PCSK9, ANGPTL3, HSD17B13, KHK, ASGR1, GPR75, CIDEB, and INHBE. Drug types primarily include small molecules
Breakthroughs March 28,2024
Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

by Sichuan International Medical Exchange and Promotion AssociationTargets primarily include PCSK9, ANGPTL3, HSD17B13, KHK, ASGR1, GPR75, CIDEB, and INHBE. Drug types primarily include small molecules
Breakthroughs March 28,2024
COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

by Elana GotkineFor patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, accord
Breakthroughs March 28,2024
COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

by Elana GotkineFor patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, accord
Breakthroughs March 28,2024
Researchers call for makers of new anti-obesity drugs to study results of body composition in addition to weight loss

Researchers call for makers of new anti-obesity drugs to study results of body composition in addition to weight loss

by Alvin Powell, Harvard GazetteCredit: Unsplash/CC0 Public DomainSome health care professionals are growing concerned that amid the recent rush for the new highly effective, anti-obesity medications,
Breakthroughs March 28,2024
Researchers call for makers of new anti-obesity drugs to study results of body composition in addition to weight loss

Researchers call for makers of new anti-obesity drugs to study results of body composition in addition to weight loss

by Alvin Powell, Harvard GazetteCredit: Unsplash/CC0 Public DomainSome health care professionals are growing concerned that amid the recent rush for the new highly effective, anti-obesity medications,
Breakthroughs March 28,2024
Lab tests show THC potency inflated on retail marijuana in Colorado

Lab tests show THC potency inflated on retail marijuana in Colorado

by Anna Schwabe,The ConversationCredit: Unsplash/CC0 Public DomainCannabis flower sold in Colorado claims to contain much more tetrahydrocannabinol, or THC, than it actually does, according to m
Breakthroughs March 28,2024
Lab tests show THC potency inflated on retail marijuana in Colorado

Lab tests show THC potency inflated on retail marijuana in Colorado

by Anna Schwabe,The ConversationCredit: Unsplash/CC0 Public DomainCannabis flower sold in Colorado claims to contain much more tetrahydrocannabinol, or THC, than it actually does, according to m
Breakthroughs March 28,2024
Removal of incorrect penicillin allergy labels by non-specialist health care professionals feasible, study shows

Removal of incorrect penicillin allergy labels by non-specialist health care professionals feasible, study shows

byUniversity of BirminghamCredit: CC0 Public DomainPatients who may have been mis-labeled as allergic to penicillin could be safely offered a dose of the oral antibiotic to demonstrate that they
Breakthroughs March 28,2024
Removal of incorrect penicillin allergy labels by non-specialist health care professionals feasible, study shows

Removal of incorrect penicillin allergy labels by non-specialist health care professionals feasible, study shows

byUniversity of BirminghamCredit: CC0 Public DomainPatients who may have been mis-labeled as allergic to penicillin could be safely offered a dose of the oral antibiotic to demonstrate that they
Breakthroughs March 28,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com